Stents are medical implants for human bodies and represent one of the most notable areas where the bio-medical industry has advanced rapidly. This advancement has been possible in part due to the foray of simulation in this area. Simulation has thus become an integral part in the design cycle of stents, helping the bio-medical industry to attain quicker turn-around times and a faster time to market.
Manufacturing is in an ecosystem in which each technology fits a specific niche. Both composite 3D printing and metal 3D printing are valuable resources – they can be used to affordably and efficiently produce many of the low volume, high-strength parts critical to the production line. In this paper, we’ll discuss how two high-strength technologies can work together to facilitate affordable and effective manufacturing – from tooling inserts to conformal workholding.
The Dassault Systèmes 3DEXPERIENCE R2018x release will mark a significant evolution for how a PLM system can manage CAD data and make it seamlessly available to other engineering functions such as simulation and process planning to pursue concurrent engineering more efficiently than ever before. Dassault Systèmes is enabling this new capability for any 3D CAD data with an approach it refers to as PLM Collaboration Services. To fully understand the significance of what PLM Collaboration Services will provide, it is first important to understand the concurrent engineering status quo at most companies and how the DS 3DEXPERIENCE engineering “authoring” applications differ from traditional CADx tools such as CATIA V5, SOLIDWORKS, Creo, Ansys, Part Planner, Mastercam, etc.
Digital technology trends such as mobility, the Internet of Things (IoT), big data and analytics are changing business processes and disrupting business models. The common denominator among them, both a transformative force and a prime enabler for all, is the cloud. The cloud delivers what businesses require to make a digital transformation: high-flexibility, on-demand access […]
Cardiovascular disease is the leading cause of death worldwide and is projected to remain so for decades, according to the World Health Organization. Surgical intervention, including the implantation of artificial pacemakers, continues to be a lifesaver for many patients.